What is Exagen Inc.'s total equity?

Exagen Inc. (XGN) reported total equity of $14.43M in Q1 2026.

How has Exagen Inc.'s total equity changed year-over-year?

Exagen Inc.'s total equity increased by 125.4% year-over-year, from $6.4M to $14.43M.

What is the long-term trend for Exagen Inc.'s total equity?

Over 5 years (2020 to 2025), Exagen Inc.'s total equity has grown at a -16.0% compound annual growth rate (CAGR), from $41.84M to $17.45M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Exagen Inc. XGN Total Equity

Total Equity at other companies

Labcorp HoldingsLH

$8.73B+5.1%

Quest DiagnosticsDGX

$7.37B+6.3%

Vor BiopharmaVOR

-$150.42M-328%

Avalo TherapeuticsAVTX

$68.32M-44.3%

CareDxCDNA

$313.54M-17.3%

Bio-Rad LaboratoriesBIO

$6.85B+2.6%

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s total equity?: Exagen Inc. (XGN) reported total equity of $14.43M in Q1 2026.
How has Exagen Inc.'s total equity changed year-over-year?: Exagen Inc.'s total equity increased by 125.4% year-over-year, from $6.4M to $14.43M.
What is the long-term trend for Exagen Inc.'s total equity?: Over 5 years (2020 to 2025), Exagen Inc.'s total equity has grown at a -16.0% compound annual growth rate (CAGR), from $41.84M to $17.45M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.